Cannabidiol (CBD) is one of two principle cannabinoids found in marijuana and hemp plants. It has well documented neuroprotective, anti-oxidant and anti-inflammatory applications. It is non-psychoactive, has few known side-effects, and is well tolerated by the young, elderly and all those in between.
CBD preparations are marketed as both a nutraceutical (e.g. CBD oil extracts, transdermal gels, vape concentrates, edibles, etc.) and as a prescription-only pharmaceutical (e.g. Epidiolex, see below for more).
A flurry of new scientific research into CBD therapeutics is showing extremely promising results. CBD is lining up to be the “next big thing” in the Health and Wellness Industry. The CBD market for 2015 was estimated at $202 million.
The Hemp Business Journal just released a report forecasting that the consumer CBD market will grow to $2.1 billion in sales by 2020! GreenWave Advisors, an independent research and financial analysis firm, is even more bullish and projects a $3 billion CBD market by 2021!
CBD legalization is here
CBD-only preparations (hemp based CBD extracts) are legal for purchase online in the majority of states in the U.S. 15 states explicitly allow for the sale of CBD-only products, with an additional 28 states where CBD extracts are also available thru regulated medical or recreational dispensaries.
CBD as a Medicine
CBDs effectiveness in treating severe forms of epilepsy is also well documented. Although still in early clinical trials, CBD preparations are saving the lives of children with severe early-onset, life-threatenting forms of epilepsy such as Dravet Syndrome and Lennox-Gastaut Syndrome.
GW Pharmaceuticals, a UK based company focused on cannabis plant-derived therapeutics, is quickly making a name for itself as a leading manufacturer of a pharmaceutical grade cannabidiol extract – Epidiolex. Epidiolex is currently under-going FDA approved clinical trials and the results are more than promising. Early reports point to a potential 50% – 75% reduction in the occurrence of seizures.
Learn more about CBD with this CBD 101 – A CBD Business Blog Exclusive
New research suggests that high doses of CBD could have anti-cancer properties and may one day be part of a wholistic anti-cancer regiment. But don’t let the FDA hear you say that. Big pharma still owns the market on FDA approved cancer treatments. As a result, you won’t see many CBD oil/extract manufacturers advertising medical benefits for their (highly effective) products.
A recent marijuana study actually concluded that CBD inhibits and kills cervical cancer cells. Click the image for a link to this exclusive article.
CBD – Where can I get it?
High-CBD strains of marijuana flower can found at most medical and recreational cannabis dispensaries. Harlequin, Charlotte’s Web, Critical Mass and Cannatonic are examples of well known, available high-CBD cannabis strains.
Vape Pens, CBD extracts, High-CBD edibles are all the rage these days. In Washington state alone, there are over 800 CBD products available to consumers (Washington’s Growing CBD Market: The Secret is Out). And the number continues to grow, creating a difficult and confusing choice for consumers and medical professionals alike.